| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55150-351-01 | 55150-351 | HUMAN PRESCRIPTION DRUG | Icatibant | Icatibant | INJECTION, SOLUTION | SUBCUTANEOUS | 20230814 | N/A | ANDA | ANDA213521 | Eugia US LLC | ICATIBANT ACETATE | 30 mg/3mL | 1 SYRINGE, GLASS in 1 CARTON (55150-351-01) / 3 mL in 1 SYRINGE, GLASS |
| 55150-351-03 | 55150-351 | HUMAN PRESCRIPTION DRUG | Icatibant | Icatibant | INJECTION, SOLUTION | SUBCUTANEOUS | 20230814 | N/A | ANDA | ANDA213521 | Eugia US LLC | ICATIBANT ACETATE | 30 mg/3mL | 3 CARTON in 1 CARTON (55150-351-03) / 1 SYRINGE, GLASS in 1 CARTON / 3 mL in 1 SYRINGE, GLASS |